Metformin decreased the expression of PD‐L1 in cancer cells by promoting abnormal PD‐L1 glycosylation and degradation, therefore blocking immune‐inhibitory signalling and enhancing antitumor immunity. The gene discussed is CD274; the disease is cancer.